On the other hand, SCFAs (e.g., propionate) promoted by DI-GM enhance insulin sensitivity by activating the AMPK pathway (81), while the low-inflammatory environment of DII reduces the interference of inflammatory factors on insulin signaling, jointly improving metabolic disorders (18). The gene discussed is INS; the disease is metabolic disease.